However, functional experiments using the selective p38-MAPK inhibitor SB203580 completely rescued the IL-21-induced effect on L-GMPs and AML cell lines, suggesting that IL-21 primarily induces p38-MAPK signaling in LSCs. The gene discussed is IL21; the disease is acute myeloid leukemia.